According to Royalty Pharma latest financial reports the company has an operating margin of 0.63%, an increase of 53.62% to 2022. At the end of 2022 company had an operating margin of 0.41%.
Year | Operating Margin | Change |
---|---|---|
2023 | 0.63% | 53.62% |
2022 | 0.41% | -33.99% |
2021 | 0.62% | -20.13% |
2020 | 0.78% | - |